캘리포니아의 골수형성이상증후군 임상 시험
골수형성이상증후군 관련 연구 41개가 캘리포니아 내 여러 지역에서 참여자를 모집하고 있습니다.
캘리포니아의 도시
- Baldwin Park연구 26개
- Los Angeles연구 10개
- Mountain View연구 9개
- Orange연구 7개
- San Francisco연구 6개
- Irvine연구 5개
- Sacramento연구 3개
- San Diego연구 3개
- Fresno연구 3개
공식 연구 텍스트(영어)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- Kaiser Permanente Dublin, Dublin
- Kaiser Permanente-Fremont, Fremont
- Kaiser Permanente Fresno Orchard Plaza, Fresno
- 외 21개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT05564390Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
- City of Hope - Duarte, Duarte
- City of Hope - Lennar, Irvine
- UCLA, Los Angeles
- 외 1개
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT05320198Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06577441A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- City of Hope - Comprehensive Cancer Center (CCC), Duarte
- Providence Medical Group, Santa Rosa
- Cancer & Blood Research Center, Whittier
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT07422480Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
- City of Hope National Medical Center, Duarte
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT06846606The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Kaiser Permanente Downey Medical Center, Downey
- Loma Linda University Medical Center, Loma Linda
- Miller Children's and Women's Hospital Long Beach, Long Beach
- 외 8개
피험자 모집 중1/2상
22세 이하 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT04726241A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
- City of Hope National Medical Center, Duarte
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 21. 업데이트됨 · NCT04419649A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- City of Hope, Duarte
- Los Angeles Cancer Network, Glendale
- UC San Diego Moores Cancer Center, La Jolla
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 21. 업데이트됨 · NCT06499285Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation
- Lucille Packard Children's Hospital of Stanford University, Palo Alto
피험자 모집 중1상
18 Months – 39 Years · 모든 성별 · 2026. 8. 21. 업데이트됨 · NCT07573111Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
- City of Hope Medical Center, Duarte
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT07582172ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT06656494TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
- Stanford University, Palo Alto
피험자 모집 중1상
18세 ~ 80세 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT07302776Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
- University of California, Los Angeles, Los Angeles
- University of California, Irvine, Orange
- Stanford Cancer Institute, Palo Alto
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT05308264225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
- City of Hope Medical Center, Duarte
피험자 모집 중1상
18세 ~ 70세 · 모든 성별 · 2026. 7. 31. 업데이트됨 · NCT06287944A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
- City of Hope Medical Center, Duarte
피험자 모집 중1상건강한 지원자 환영
18세 ~ 75세 · 모든 성별 · 2026. 7. 28. 업데이트됨 · NCT07020533Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant
- City of Hope Medical Center, Duarte
피험자 모집 중1상
18세 ~ 75세 · 모든 성별 · 2026. 7. 16. 업데이트됨 · NCT06498973Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- UCLA Department of Medicine, Los Angeles
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 7. 7. 업데이트됨 · NCT07216443A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
- City of Hope, Duarte
- UC Davis, Sacramento
- Stanford Health Care, Stanford
피험자 모집 중1상
12세 ~ 78세 · 모든 성별 · 2026. 7. 1. 업데이트됨 · NCT03802695Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
- City of Hope Medical Center, Duarte
피험자 모집 중1상
18세 ~ 75세 · 모든 성별 · 2026. 7. 1. 업데이트됨 · NCT06996119Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
- City of Hope Medical Center, Duarte
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT06815003Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT
- Stanford University, Palo Alto
피험자 모집 중1상
18세 ~ 70세 · 모든 성별 · 2026. 6. 23. 업데이트됨 · NCT06551584SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- City of Hope, Duarte
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 17. 업데이트됨 · NCT03113643A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
- GSK Investigational Site, Duarte
- GSK Investigational Site, Irvine
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 6. 2. 업데이트됨 · NCT06847867A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Keck School of Medicine of USC, Los Angeles
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 4. 30. 업데이트됨 · NCT04256317Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- Beckman Research Institute of City of Hope, Duarte
- VA Medical Center, Fresno, Fresno
- Santa Clara Valley Medical Center, Fruitdale
- 외 5개
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 4. 30. 업데이트됨 · NCT05297734Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
- City of Hope Medical Center, Duarte
피험자 모집 중1상건강한 지원자 환영
60세 이상 · 모든 성별 · 2026. 4. 29. 업데이트됨 · NCT06195891A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
- City of Hope Medical Center, Duarte
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 4. 13. 업데이트됨 · NCT06146257Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 3. 27. 업데이트됨 · NCT06063486A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Hoag Family Cancer Center, Newport Beach
- Stanford University, Palo Alto
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 3. 24. 업데이트됨 · NCT04988555Venetoclax Basket Trial for High Risk Hematologic Malignancies
- University of California San Francisco-Benioff Children's Hospital, San Francisco
피험자 모집 중1상
1세 ~ 40세 · 모든 성별 · 2026. 3. 12. 업데이트됨 · NCT05292664CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
- City of Hope Medical Center, Duarte
피험자 모집 중2상건강한 지원자 환영
18세 ~ 75세 · 모든 성별 · 2026. 3. 10. 업데이트됨 · NCT06059391Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant
- City of Hope Medical Center, Duarte
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 3. 5. 업데이트됨 · NCT06543381CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
- UCLA, Los Angeles
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 1. 16. 업데이트됨 · NCT05143996Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- University of California Davis Health (UC Davis Health), Sacramento
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 1. 5. 업데이트됨 · NCT05184842Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
- City of Hope Medical Center, Duarte
피험자 모집 중2상
10세 ~ 30세 · 모든 성별 · 2025. 12. 4. 업데이트됨 · NCT05194397Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
- City of Hope Medical Center, Duarte
피험자 모집 중2상
2세 ~ 22세 · 모든 성별 · 2025. 10. 31. 업데이트됨 · NCT06128070SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Duarte
- Massive Bio SYNERGY-AI site, Irvine
- Massive Bio SYNERGY-AI site, La Jolla
- 외 3개
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
- City of Hope Medical Center, Duarte
- University of California Los Angeles, Los Angeles
- Stanford Cancer Center, Palo Alto
피험자 모집 중1상
18세 이상 · 모든 성별 · 2025. 9. 24. 업데이트됨 · NCT06501196Study of REM-422 in Patients With AML or Higher Risk MDS
- City of Hope, Duarte
피험자 모집 중1상
18세 이상 · 모든 성별 · 2025. 4. 23. 업데이트됨 · NCT06297941Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- City of Hope, Duarte
피험자 모집 중1상
18세 이상 · 모든 성별 · 2025. 4. 15. 업데이트됨 · NCT06462365ClinicalTrials.gov 출처, 2026. 9. 29. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.